Viewing Study NCT01714193


Ignite Creation Date: 2025-12-25 @ 1:23 AM
Ignite Modification Date: 2025-12-26 @ 12:04 AM
Study NCT ID: NCT01714193
Status: COMPLETED
Last Update Posted: 2012-11-19
First Post: 2012-10-23
Is Gene Therapy: True
Has Adverse Events: False

Brief Title: A Study to Assess the Effects of Canagliflozin (JNJ-28431754) on the Pharmacokinetics and Safety of an Oral Contraceptive in Healthy Volunteers
Sponsor: Johnson & Johnson Pharmaceutical Research & Development, L.L.C.
Organization:

Key Dates - Follows AllAPIJSON File Order

Start Date: 2008-02
Start Date Type: None
Primary Completion Date: 2008-03
Primary Completion Date Type: ACTUAL
Completion Date: 2008-03
Completion Date Type: ACTUAL
First Submit Date: 2012-10-23
First Submit QC Date: None
Study First Post Date: 2012-10-25
Study First Post Date Type: ESTIMATED
Results First Submit Date: None
Results First Submit QC Date: None
Results First Post Date: None
Results First Post Date Type: None
Results First Post QC Date: None
Results First Post QC Date Type: None
Disp First Submit Date: None
Disp First Submit QC Date: None
Disp First Post Date: None
Disp First Post Date Type: None
Last Update Submit Date: 2012-11-16
Last Update Post Date: 2012-11-19
Last Update Post Date Type: ESTIMATED